Synthesis and structure activity relationship of 1, 3-benzo-thiazine-2-thiones as selective HDAC8 inhibitors

Human histone deacetylase 8 (HDAC8) is a highly promising target for neuroblastoma and other types of cancer. Several HDAC inhibitors are approved for the treatment of special cancer subtypes or are evaluated in clinical trials. By far the most drugs or drug candidates contain a hydroxamate group th...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Wolff, Benjamin (VerfasserIn) , Jänsch, Niklas (VerfasserIn) , Sugiarto, Wisely Oki (VerfasserIn) , Frühschulz, Stefan (VerfasserIn) , Lang, Maraike (VerfasserIn) , Altintas, Rabia (VerfasserIn) , Oehme, Ina (VerfasserIn) , Meyer-Almes, Franz-Josef (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 7 October 2019
In: European journal of medicinal chemistry
Year: 2019, Jahrgang: 184, Pages: 1-20
ISSN:1768-3254
DOI:10.1016/j.ejmech.2019.111756
Online-Zugang:Verlag, Volltext: https://doi.org/10.1016/j.ejmech.2019.111756
Verlag, Volltext: http://www.sciencedirect.com/science/article/pii/S0223523419309080
Volltext
Verfasserangaben:Benjamin Wolff, Niklas Jänsch, Wisely Oki Sugiarto, Stefan Frühschulz, Maraike Lang, Rabia Altintas, Ina Oehme, Franz-Josef Meyer-Almes

MARC

LEADER 00000caa a2200000 c 4500
001 1690459034
003 DE-627
005 20240710090957.0
007 cr uuu---uuuuu
008 200220s2019 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.ejmech.2019.111756  |2 doi 
035 |a (DE-627)1690459034 
035 |a (DE-599)KXP1690459034 
035 |a (OCoLC)1341307553 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Wolff, Benjamin  |e VerfasserIn  |0 (DE-588)120508455X  |0 (DE-627)1690465026  |4 aut 
245 1 0 |a Synthesis and structure activity relationship of 1, 3-benzo-thiazine-2-thiones as selective HDAC8 inhibitors  |c Benjamin Wolff, Niklas Jänsch, Wisely Oki Sugiarto, Stefan Frühschulz, Maraike Lang, Rabia Altintas, Ina Oehme, Franz-Josef Meyer-Almes 
264 1 |c 7 October 2019 
300 |a 20 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 20.02.2020 
520 |a Human histone deacetylase 8 (HDAC8) is a highly promising target for neuroblastoma and other types of cancer. Several HDAC inhibitors are approved for the treatment of special cancer subtypes or are evaluated in clinical trials. By far the most drugs or drug candidates contain a hydroxamate group that chelates the catalytic zinc ion within HDACs. Most hydroxamate inhibitors are more or less unselective, although there are considerable exceptions demonstrating the general feasibility to develop at least HDAC isoenzyme selective inhibitors. In addition, hydroxamates have recently come under discussion regarding their potential for mutagenicity. Recently, PD-404,182 was discovered as a selective and potent non-hydroxamate inhibitor of HDAC8. However, this active compound turned out to be decomposed in the presence of glutathion (GSH). Here, we describe the synthesis of significantly improved analogs of PD-404,182 that demonstrate both, great selectivity for HDAC8 and also chemical stability in the presence of GSH. The compounds are characterized with respect to structure-activity relationship, binding mode and target engagement in neuroblastoma cells by combining biochemical and biophysical methods with chemoinformatics. 
650 4 |a Cancer 
650 4 |a Drug design 
650 4 |a Drug discovery 
650 4 |a Histone deacetylase 8 
650 4 |a Neuroblastoma 
650 4 |a Non-chelating inhibitor 
700 1 |a Jänsch, Niklas  |e VerfasserIn  |4 aut 
700 1 |a Sugiarto, Wisely Oki  |e VerfasserIn  |4 aut 
700 1 |a Frühschulz, Stefan  |e VerfasserIn  |4 aut 
700 1 |a Lang, Maraike  |e VerfasserIn  |4 aut 
700 1 |a Altintas, Rabia  |e VerfasserIn  |0 (DE-588)1205084762  |0 (DE-627)1690465239  |4 aut 
700 1 |a Oehme, Ina  |d 1974-  |e VerfasserIn  |0 (DE-588)129573388  |0 (DE-627)473352621  |0 (DE-576)297728652  |4 aut 
700 1 |a Meyer-Almes, Franz-Josef  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t European journal of medicinal chemistry  |d Amsterdam [u.a.] : Elsevier Science, 1987  |g 184(2019), Artikel-ID 111756, Seite 1-20  |h Online-Ressource  |w (DE-627)320443213  |w (DE-600)2005170-0  |w (DE-576)25927125X  |x 1768-3254  |7 nnas  |a Synthesis and structure activity relationship of 1, 3-benzo-thiazine-2-thiones as selective HDAC8 inhibitors 
773 1 8 |g volume:184  |g year:2019  |g elocationid:111756  |g pages:1-20  |g extent:20  |a Synthesis and structure activity relationship of 1, 3-benzo-thiazine-2-thiones as selective HDAC8 inhibitors 
856 4 0 |u https://doi.org/10.1016/j.ejmech.2019.111756  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u http://www.sciencedirect.com/science/article/pii/S0223523419309080  |x Verlag  |3 Volltext 
951 |a AR 
992 |a 20200220 
993 |a Article 
994 |a 2019 
998 |g 129573388  |a Oehme, Ina  |m 129573388:Oehme, Ina  |d 50000  |e 50000PO129573388  |k 0/50000/  |p 7 
998 |g 1205084762  |a Altintas, Rabia  |m 1205084762:Altintas, Rabia  |d 50000  |e 50000PA1205084762  |k 0/50000/  |p 6 
999 |a KXP-PPN1690459034  |e 3596999936 
BIB |a Y 
SER |a journal 
JSO |a {"relHost":[{"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title_sort":"European journal of medicinal chemistry","title":"European journal of medicinal chemistry"}],"part":{"extent":"20","year":"2019","text":"184(2019), Artikel-ID 111756, Seite 1-20","pages":"1-20","volume":"184"},"note":["Gesehen am 22.11.04"],"pubHistory":["Nachgewiesen 22.1987 -"],"language":["eng"],"disp":"Synthesis and structure activity relationship of 1, 3-benzo-thiazine-2-thiones as selective HDAC8 inhibitorsEuropean journal of medicinal chemistry","origin":[{"dateIssuedDisp":"1987-","publisherPlace":"Amsterdam [u.a.]","dateIssuedKey":"1987","publisher":"Elsevier Science"}],"id":{"issn":["1768-3254"],"eki":["320443213"],"zdb":["2005170-0"]},"recId":"320443213","type":{"bibl":"periodical","media":"Online-Ressource"}}],"title":[{"title":"Synthesis and structure activity relationship of 1, 3-benzo-thiazine-2-thiones as selective HDAC8 inhibitors","title_sort":"Synthesis and structure activity relationship of 1, 3-benzo-thiazine-2-thiones as selective HDAC8 inhibitors"}],"physDesc":[{"extent":"20 S."}],"language":["eng"],"note":["Gesehen am 20.02.2020"],"person":[{"given":"Benjamin","display":"Wolff, Benjamin","family":"Wolff","role":"aut"},{"display":"Jänsch, Niklas","role":"aut","family":"Jänsch","given":"Niklas"},{"given":"Wisely Oki","role":"aut","family":"Sugiarto","display":"Sugiarto, Wisely Oki"},{"role":"aut","family":"Frühschulz","display":"Frühschulz, Stefan","given":"Stefan"},{"given":"Maraike","display":"Lang, Maraike","family":"Lang","role":"aut"},{"family":"Altintas","role":"aut","display":"Altintas, Rabia","given":"Rabia"},{"role":"aut","family":"Oehme","display":"Oehme, Ina","given":"Ina"},{"given":"Franz-Josef","role":"aut","family":"Meyer-Almes","display":"Meyer-Almes, Franz-Josef"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"id":{"eki":["1690459034"],"doi":["10.1016/j.ejmech.2019.111756"]},"recId":"1690459034","name":{"displayForm":["Benjamin Wolff, Niklas Jänsch, Wisely Oki Sugiarto, Stefan Frühschulz, Maraike Lang, Rabia Altintas, Ina Oehme, Franz-Josef Meyer-Almes"]},"origin":[{"dateIssuedDisp":"7 October 2019","dateIssuedKey":"2019"}]} 
SRT |a WOLFFBENJASYNTHESISA7201